4 hours Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects ItSeeking Alpha

Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It.

Pharmaceuticals · Vertex (VRTX)

20 mins Rhythm Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

2 hours Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks X

2 hours Syndax Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

4 hours Why Apellis Pharmaceuticals Stock Was Tumbling on TuesdayThe Motley Fool X

5 hours Apellis Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

5 hours Apellis Pharmaceuticals, Inc. (APLS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

6 hours Earnings call: Supernus Pharmaceuticals reported a significant increase in total revenueInvesting.com X

9 hours PFE or NVO: Which Is the Better Value Stock Right Now?Zacks X

9 hours VRTX Q3 Earnings & Sales Trump Estimates, ’24 Sales View RaisedZacks X

21 hours What the vote means for corporate AmericaFinancial Times X

22 hours Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

24 hours Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call TranscriptThe Motley Fool X

24 hours Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

24 hours Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

1 day Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to SayZacks X

1 day Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue EstimatesZacks X

1 day Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug LoomsInvestor's Business Daily X

1 day BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call TranscriptThe Motley Fool X

2 days BioCryst Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

2 days BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue EstimatesZacks X

2 days Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European ExpansionSeeking Alpha X

3 days ANI Pharmaceuticals Is Acting Like It Is Being AcquiredSeeking Alpha X

3 days Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

4 days Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to ConsiderZacks X

4 days Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS GroupMarketBeat X

4 days Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 8.5% – What’s Next?MarketBeat X

4 days Healthcare Investing Finding Growth Beyond PharmaceuticalsSeeking Alpha X

4 days Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High – Here’s What HappenedMarketBeat X

4 days Scotiabank Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) StockMarketBeat X

4 days Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to DeclineZacks X

4 days Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to DeclineZacks X

4 days Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock UpZacks X

5 days Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock DownZacks X

5 days Fennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on ThursdayMarketBeat X

5 days Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarketBeat X

5 days Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on FridayMarketBeat X

6 days Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat X

6 days Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?Zacks X

6 days Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $35.00MarketBeat X

6 days Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?Zacks X

6 days Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks X

6 days Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest UpdateMarketBeat X

7 days AMI Asset Management Corp Purchases Shares of 51,262 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)MarketBeat X

7 days DekaBank Deutsche Girozentrale Acquires 31,283 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MarketBeat X

7 days Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by AnalystsMarketBeat X

7 days Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from AnalystsMarketBeat X

1 week Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Up 9.7% – Here’s WhyMarketBeat X

1 week Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 12-Month High – What’s Next?MarketBeat X

1 week EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 6.5% – Should You Sell?MarketBeat X

1 week Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Down – Should You Sell?MarketBeat X